title: Combination endocrine treatments unproven in breast cancer.
authors.affiliation: Department of Breast Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. abuzdar@mdanderson.org
authors.forename: Aman U
authors.initials: AU
authors.lastname: Buzdar
mesh_terms: D000077384:Anastrozole; D000730:Androstadienes / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D047072:Aromatase Inhibitors / Q000008:administration & dosage*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004965:Estrogen Antagonists / Q000008:administration & dosage*; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D009570:Nitriles / Q000008:administration & dosage*; D014230:Triazoles / Q000008:administration & dosage*
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; D047072:Aromatase Inhibitors; D004965:Estrogen Antagonists; D009570:Nitriles; D014230:Triazoles; D000077267:Fulvestrant; D000077384:Anastrozole; D004958:Estradiol; C056516:exemestane